Skip to content

Clinical trials

Active, not recruiting Carcinoma, Hepatocellular trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Active, not recruiting Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20184
20192
20211
20221
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
University Health Network, Toronto2
ABK Biomedical1
AbbVie1
Bristol-Myers Squibb1
Coherus Oncology, Inc.1
Eisai Inc.1
Exelixis1
Hoffmann-La Roche1
ImmunoVaccine Technologies, Inc. (IMV Inc.)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular14
Liver Neoplasms6
Neoplasms3
Colorectal Neoplasms2
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Endometrial Neoplasms1
Liver Diseases1
Neoplasm Metastasis1
Ovarian Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.